Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
How did RVTY's recent EPS compare to expectations?
The most recent EPS for Revvity Inc is $1.7, beating expectations of $1.58.
How did Revvity Inc RVTY's revenue perform in the last quarter?
Revvity Inc revenue for the last quarter is $1.7
What is the revenue estimate for Revvity Inc?
According to 18 of Wall street analyst, the revenue estimate of Revvity Inc range from $745.47M to $667.77M
What's the earning quality score for Revvity Inc?
Revvity Inc has a earning quality score of B+/56.207134. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Revvity Inc report earnings?
Revvity Inc next earnings report is expected in 2026-05-03
What are Revvity Inc's expected earnings?
Revvity Inc expected earnings is $776.51M, according to wall-street analysts.
Did Revvity Inc beat earnings expectations?
Revvity Inc recent earnings of $772.05M does not beat expectations.